T.Martino_45
Recently Joined
Research Study:
https://www.researchgate.net/public...ma_Can_Tirzepatide_Overcome_the_Treatment_Gap
What is the goal of ATX-304 development?
https://www.researchgate.net/public...ma_Can_Tirzepatide_Overcome_the_Treatment_Gap
What is the goal of ATX-304 development?
- The ultimate goal is to develop ATX-304 as a treatment for chronic weight management and associated cardiometabolic disorders.
- Metabolic health: Improves insulin sensitivity, lowers fasting glucose, and reduces hyperinsulinemia.
- Obesity and fat loss: Reduces fat mass rapidly in animal studies, preserving lean muscle.
- Cardiovascular health: Lowers blood pressure, increases cardiac stroke volume, and improves microvascular perfusion.
- Liver health: Protects against fatty liver (MASLD/NASH) by decreasing steatosis and fibrosis.
- Kidney protection: Reduces serum creatinine and renal injury markers in cisplatin-induced AKI models.
- Aging and longevity: Prevents age-related insulin resistance and preserves exercise capacity in older mice.
- ATX-304 helps the body burn glucose and fat more efficiently, improves circulation, protects organs under stress, and supports healthy aging.
